Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell, James A
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials. [electronic resource] - Journal of critical care 10 2018 - 333-337 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-8615
10.1016/j.jcrc.2018.05.003 doi
Clinical Trials as Topic
Dobutamine--therapeutic use
Dopamine--therapeutic use
Epinephrine--therapeutic use
Humans
Neurophysins--metabolism
Norepinephrine--therapeutic use
Protein Precursors--metabolism
Randomized Controlled Trials as Topic
Shock--mortality
Shock, Septic--drug therapy
Time Factors
Treatment Outcome
Vasoconstrictor Agents--therapeutic use
Vasopressins--metabolism
Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials. [electronic resource] - Journal of critical care 10 2018 - 333-337 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1557-8615
10.1016/j.jcrc.2018.05.003 doi
Clinical Trials as Topic
Dobutamine--therapeutic use
Dopamine--therapeutic use
Epinephrine--therapeutic use
Humans
Neurophysins--metabolism
Norepinephrine--therapeutic use
Protein Precursors--metabolism
Randomized Controlled Trials as Topic
Shock--mortality
Shock, Septic--drug therapy
Time Factors
Treatment Outcome
Vasoconstrictor Agents--therapeutic use
Vasopressins--metabolism